Cancer biomarkers in diagnostics and pharmacotherapy
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Presentation
- By: TANIGAWARA, Yusuke (Keio University, School of Medicine, Department of Clinical Pharmacokinetics and Pharmacodynamics, Tokyo, Japan)
Efficacy of cancer pharmacotherapy depends upon drug exposure to the body and responsiveness of the tumor to the drug treatment. Drug exposure is determined by pharmacokinetics and dose, whereas responsiveness is variable by tumor heterogeneity. Recently, a number of molecular targeting agents are used as promising therapy for cancers, and most of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.